Significant Generics Opportunity

Source: IMS and analyst reports; internal McKesson analysis

Branded pharmaceuticals going off patent

Should drive significant generic growth and margin expansion

• 24% share of

independent segment

• 20,000 pharmacy outlets

• Generic Rx GP% can be 3-5x

that of branded Rx

Previous slide

Next slide

Back to first slide

View graphic version